Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).Robert L. Ferris, Barbara Burtness, Joaquín J. García et al.|Journal of Clinical Oncology|2020Cited by 101
Updated report of a phase II randomized trial of transoral surgical resection followed by low-dose or standard postoperative therapy in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN cancer research group (E3311).Robert L. Ferris, Barbara Burtness, Yael Flamand et al.|Journal of Clinical Oncology|2021Cited by 26
Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.Ranee Mehra, Robert L. Ferris, Yael Flamand et al.|Journal of Clinical Oncology|2022Cited by 12